The publication aims to assess the impact of the risk-minimization measures applied in 2017 and comparing the current trends to fluoroquinolone use to those from a previous drug utilization study conducted by CNODES.
Citation
Ernst, P., Lix, L.M., Carney, G. Daneman, N., Dahl, M., Dawn-Scory, T., Dutton, D., Feng, X., Janzen, D. et al. Use of Oral Fluoroquinolones in Canada: A Drug Utilization Study Update (2024). https://www.cda-amc.ca/use-oral-fluoroquinolones-canada-drug-utilization-study-update
https://www.cda-amc.ca/use-oral-fluoroquinolones-canada-drug-utilization-study-update